M&A M&A
Corona Remedies acquires antiseptic brand Wokadine from DRL
Source Business Standard (opens in a new tab)BSE Announcement (opens in a new tab)
Ahmedabad-based Corona Remedies has acquired the antiseptic brand Wokadine from Dr Reddy's Laboratories (DRL). The acquisition was fully funded through internal accruals and cash.Wokadine is a broad-spectrum antiseptic used for treating and preventing infections in minor cuts, burns, wounds, and for pre-operative skin preparation. Previously, Corona had acquired seven brands from Bayer and the pain management brand Myoril from Sanofi.